Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found. The results, reported in ...
WHO extends emergency status of Ebola in Congo but welcomes sharp decline in cases
The U.N. health agency on Wednesday said it was extending its global emergency designation for the Ebola outbreak in DR Congo but said the sharp decline in cases was "extremely positive. The recent outbreak was first identified in August 2018 and has since killed more ...
U.S. working with pharmaceutical firm on new type of coronavirus treatment
The United States is working with a pharmaceutical company to develop a treatment for the 2019 novel coronavirus, using a class of drug that has boosted survival rates among Ebola patients, officials said Tuesday. The partnership between the Department of Health and Human Services (HHS) ...
Thirty-six people have been killed in a suspected militia attack in the eastern DR Congo region of Beni, where hundreds have died in violence since November, a local official said Wednesday. Congolese troops have been carrying out a military operation on an armed group in ...
U.S. developing vaccine against deadly China virus and urges Beijing cooperation
The United States said Tuesday it was developing a vaccine against a deadly virus that originated in China, and urged Beijing to step up its cooperation with international health authorities. The U.S. government is keen to place its own teams on the ground to review ...
A tragic airline crash with far-reaching consequences, cataclysmic cyclones that may be a harbinger of the future, the death of an African icon and a new leader who won the Nobel Peace Prize. These African stories captured the world's attention in 2019 — and ...
Tokyo University team to start first clinical trials of new Ebola vaccine
A team of University of Tokyo researchers said Thursday it will begin later this month the nation's first clinical study on a vaccine for the Ebola virus. The new vaccine developed by Yoshihiro Kawaoka, a professor at the university's Institute of Medical Science, and others ...
Congo's Ebola outbreak slows but still entrenched in insecure areas: WHO
The Ebola epidemic in northeastern Democratic Republic of Congo has been confined to a rural area rife with militias and people on the move, making it harder to stamp out altogether, the World Health Organization (WHO) said Thursday. Only 14 confirmed infections were reported last ...
Japan imports Ebola virus for research ahead of 2020 Olympics visitor influx
Strains of Ebola and four other deadly viruses have been imported to Japan for the development of diagnostic kits ahead of an expected influx of visitors for the 2020 Olympics and Paralympics in Tokyo, a governmental research institute said Friday. The viruses were taken to ...
The world faces a mounting threat of pandemics that could kill millions and wreak economic havoc, a international expert panel warns, saying governments should work to mitigate that risk. The Global Preparedness Monitoring Board, convened by the World Bank and the World Health Organization, said ...
How to stop deadly outbreaks of diseases like Ebola — before they occur
In today's interconnected world, disease outbreaks do not respect national borders.
For countries to grow, health care must come first, WHO's Africa director says on TICAD sidelines
Matshidiso Moeti has been one of Africa's foremost caretakers for more than three decades. Last week, she was nominated by 47 member states of the World Health Organization to serve a second five-year term as regional director for Africa, and this week in Yokohama she ...
